pharmacological interventions can be envisaged to try to counteract the deficits observed. Here, . et al. 0 we review the available human and mouse data and present how they have been and could be used in the development of pharmacological treatments for children affected by the syndrome. Given our current knowledge and the tools available - issue: - volume: - pages: .
J Med Genet. 2010 Jan, . et al. 0 Mencarelli MA 10.1136/jmg.2009.067884 - issue: - volume: - pages: .